We are dedicated to working towards prevention of Alzheimer's Disease through biomarker-based disease prediction
BeauBrain Healthcare has raised $3.0M in total funding. The most recent round was Series A. The last funding was announced in August 2024.
BeauBrain Healthcare's investors include Daewoong Pharmaceutical, Lotte Ventures, Aju IB Investment, L&S Venture Capital, Mint Venture Partners.
BeauBrain Healthcare is headquartered in Seoul, South Korea.
We are dedicated to working towards prevention of Alzheimer's Disease through biomarker-based disease prediction
BeauBrain Healthcare is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BeauBrain Healthcare — Funding & Investors." VCBacked, August 23, 2024, https://www.vcbacked.co/company/beaubrain-healthcare. Accessed July 31, 2026.
VCBacked. (2024). BeauBrain Healthcare — Funding & Investors. Retrieved July 31, 2026, from https://www.vcbacked.co/company/beaubrain-healthcare
{{cite web |title=BeauBrain Healthcare — Funding & Investors |url=https://www.vcbacked.co/company/beaubrain-healthcare |website=VCBacked |access-date=July 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated